<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Xylometazoline (United States: Not available): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Xylometazoline (United States: Not available): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Xylometazoline (United States: Not available): Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="106758" href="/d/html/106758.html" rel="external">see "Xylometazoline (United States: Not available): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="list canbnlist drugH1Div drugBrandNames" id="F52914289"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Balminil Decongest [OTC];</li>
<li>Otrivin [OTC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F235001"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Alpha-Adrenergic Agonist;</li>
<li>
                        Decongestant;</li>
<li>
                        Imidazoline Derivative</li></ul></div>
<div class="block doa drugH1Div" id="F234974"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="aa6069be-77fb-4807-b092-cbf82db43773">Nasal congestion</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;">
<b>Nasal congestion:</b>
<b>Intranasal:</b> Spray: 2 sprays in each nostril every 8 to 10 hours (maximum: 6 sprays in each nostril daily).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F56581084"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F56581085"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F234975"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F234959"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Central nervous system: Headache</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gastrointestinal: Nausea</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Local: Application site burning</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Respiratory: Dry nose, nasal discomfort</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">&lt;1%, postmarketing, and/or case reports: Cardiac arrhythmia, hypersensitivity reaction, tachycardia, visual impairment (transient)</p></div>
<div class="block coi drugH1Div" id="F46106201"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to xylometazoline or any component of the formulation; patients with transphenoidal hypophysectomy or surgery exposing the dura mater; narrow angle glaucoma; rhinitis sicca or atrophic rhinitis</p></div>
<div class="block war drugH1Div" id="F46106227"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Rebound nasal congestion: Frequent or prolonged use may cause nasal congestion to recur or worsen.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Cardiovascular disease: Use with caution in patients with hypertension or heart disease.</p>
<p style="text-indent:-2em;margin-left:4em;">• Diabetes mellitus: Use with caution in patients with diabetes mellitus.</p>
<p style="text-indent:-2em;margin-left:4em;">• Thyroid disease: Use with caution in patients with thyroid disease.</p>
<p style="text-indent:-2em;margin-left:4em;">• Prostatic hyperplasia/Urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: If symptoms persist longer than 3 days consult health care provider. Container should not be used by more than 1 individual.</p></div>
<div class="block prod-avail drugH1Div" id="F46106895"><span class="drugH1">Product Availability</span>
<p style="text-indent:0em;display:inline">Not available in the United States.</p></div>
<div class="block dinfoc drugH1Div" id="F52914290"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">Solution, Nasal, as hydrochloride [spray]: 0.1%</p></div>
<div class="block adm drugH1Div" id="F46106891"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Intranasal: </b>For intranasal use only. Before first use, prime pump by spraying several times into air until a fine mist appears. Blow nose to clear nostrils before use. Tilt head slightly backward and then spray solution into each nostril. After application inhale deeply. Wipe tip of container clean after each use.</p></div>
<div class="block use drugH1Div" id="F234965"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Note: </b>Not available in the United States.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Nasal Congestion:</b> Temporary relief of nasal and nasopharyngeal mucosal congestion</p></div>
<div class="block mst drugH1Div" id="F235005"><span class="drugH1">Medication Safety Issues</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Sound-alike/look-alike issues: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Otrivin may be confused with Lotrimin</p></div>
<div class="block cyt drugH1Div" id="F13300230"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F234960"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Alpha1-Blockers: May diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Atomoxetine: May enhance the hypertensive effect of Sympathomimetics. Atomoxetine may enhance the tachycardic effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Atropine (Systemic): May enhance the hypertensive effect of Alpha1-Agonists.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Bromocriptine: May enhance the hypertensive effect of Alpha1-Agonists. Management: Consider alternatives to this combination when possible. If combined, monitor for hypertension and tachycardia, and do not coadminister these agents for more than 10 days.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cannabinoid-Containing Products: May enhance the tachycardic effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cocaine (Topical): May enhance the hypertensive effect of Sympathomimetics. Management: Consider alternatives to use of this combination when possible. Monitor closely for substantially increased blood pressure or heart rate and for any evidence of myocardial ischemia with concurrent use.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Doxofylline: Sympathomimetics may enhance the adverse/toxic effect of Doxofylline. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ergot Derivatives (Vasoconstrictive CYP3A4 Substrates): May enhance the vasoconstricting effect of Alpha1-Agonists.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Esketamine: Decongestants (Nasally Administered) may diminish the therapeutic effect of Esketamine.  Management: Patients who require a nasal decongestant on an esketamine dosing day should administer the nasal decongestant at least 1 hour before esketamine.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">FentaNYL: Decongestants may decrease the serum concentration of FentaNYL. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Guanethidine: May enhance the arrhythmogenic effect of Sympathomimetics. Guanethidine may enhance the hypertensive effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Iobenguane Radiopharmaceutical Products: Alpha1-Agonists may diminish the therapeutic effect of Iobenguane Radiopharmaceutical Products.  Management: Discontinue all drugs that may inhibit or interfere with catecholamine transport or uptake for at least 5 biological half-lives before iobenguane administration. Do not administer these drugs until at least 7 days after each iobenguane dose.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Kratom: May enhance the adverse/toxic effect of Sympathomimetics.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Levothyroxine: May enhance the adverse/toxic effect of Sympathomimetics. Specifically, the risk of coronary insufficiency may be increased in patients with coronary artery disease. Levothyroxine may enhance the therapeutic effect of Sympathomimetics. Sympathomimetics may enhance the therapeutic effect of Levothyroxine.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Linezolid: May enhance the hypertensive effect of Sympathomimetics. Management: Consider initial dose reductions of sympathomimetic agents, and closely monitor for enhanced blood pressure elevations, in patients receiving linezolid.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Lisuride: May enhance the hypertensive effect of Alpha1-Agonists.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Monoamine Oxidase Inhibitors: May enhance the hypertensive effect of Alpha1-Agonists. While linezolid is expected to interact via this mechanism, management recommendations differ from other monoamine oxidase inhibitors.  Refer to linezolid specific monographs for details.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ozanimod: May enhance the hypertensive effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Pergolide: May enhance the hypertensive effect of Alpha1-Agonists.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Solriamfetol: Sympathomimetics may enhance the hypertensive effect of Solriamfetol. Sympathomimetics may enhance the tachycardic effect of Solriamfetol. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tedizolid: May enhance the hypertensive effect of Sympathomimetics. Tedizolid may enhance the tachycardic effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tricyclic Antidepressants: May enhance the therapeutic effect of Alpha1-Agonists. Tricyclic Antidepressants may diminish the therapeutic effect of Alpha1-Agonists.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Zavegepant: Decongestants (Nasally Administered) may decrease the serum concentration of Zavegepant.  Management: Avoid the concurrent administration of intranasal decongestants with zavegepant. If combined use is unavoidable, intranasal decongestants should be administered at least 1 hour after zavegepant administration.<i> Risk D: Consider therapy modification</i></p></div>
<div class="block pri drugH1Div" id="F46106195"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">According to the manufacturer, use during pregnancy is not recommended.</p></div>
<div class="block brc drugH1Div" id="F46106198"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">It is not known if xylometazoline is excreted in breast milk. The manufacturer recommends that caution be exercised when administering xylometazoline to nursing women.</p></div>
<div class="block pha drugH1Div" id="F234956"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Stimulates alpha-adrenergic receptors in the arterioles of the conjunctiva and the nasal mucosa to produce vasoconstriction</p></div>
<div class="block phk drugH1Div" id="F234967"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Onset of action: Intranasal: Local vasoconstriction: Within 2 minutes</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Duration: Up to 12 hours</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F234968"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Balkis | Decozal | Olynth | Otrivin | Xylo | Xylo comod | Xylolin | Xylomet</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Nastizol | Orla-xyl | Otrivina | Otrivina spray nasal | Xylometazolina</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Easynasan | Hysan | Otrivin | Snup</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Flo Xylo-Pos | Otrivin | Otrivin junior</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Antazol | Nazol | Novin | Rhinozol | Xylomet | Xylovin</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Nasa rhinathiol | NasaSinutab | Nuso san | Otrivine | Rhinivex | Xylomaris | Xylometazoline eg | Xyloteva</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Biomist nd | Biomist ns | Otrivine</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Olynth | Otrivin | Rhinoxylin | Xylometazolin | Xylomethazolin | Xylopharm | Xylorhin | Xymeral</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Orlaxyl | Otrivina</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Coop vitality xylometazolin | Nasenspray Neo | Olynth | Olynth Microdoseur | Otrivin | Rhinostop | Rinosedin | Xylo</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Biomist nd | Biomist ns | Rinasan | Xylonet</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Nuo tong | Nuotong | Tian cheng nuo er</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Colirio azul</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Mar rhino | Nasenspray | Nasentropfen | Olynth | Otrivin | Rinoxyl | Xylomax | Xylomax neo | Xylometazolin dr.max</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Apo rot nasenspray | Axea | Balkis | Balkis nase | Brufasol | Docmorris xylo | Gelonasal | Gib | Hysan Schnupfenspray | Imidin | Imidin N | Klindwort | Medicon Xylometazolin | Medpex | Mein nasenspray vita | Nasan | Nasenspray | Nasenspray Axcount | Nasenspray disapo | Nasenspray e | Nasenspray Elac | Nasenspray ipa | Nasenspray ipa/ba | Nasenspray ipa/klindwort | Nasenspray ipa/mpk | Nasenspray medicamo | Nasenspray Teva | Nasenspray wepa | Nasenspray zentiva | Nasentropfen | Nasentropfen Axcount | Nasentropfen e | Nasentropfen k | Nasentropfen Stada | Neovel + | Neovel med | Olynth | Otriven | Otriven gegen schnupfen | Otriven Sinuspray | Otrivin | Rapako xylo | Rhinex mit Xylometazolin | Rhino Stas | Schnupfen endrine | Stas nase | Xylo | Xylo aiwa | Xylo redcare | Xylomet abz | Xylometazolin | Xylometazolin ap | Xylometazoline adjupharm</span>;</li>
<li>
<span class="countryCode">(DK)</span> <span class="country">Denmark</span><span class="countrySeparator">: </span><span class="drugName">Klarigen | Passagen | Zymelin menthol ukonserveret | Zymelin ukonserveret</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Nozolin | Otrivina | Rhynofar</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Constrilin | Otrivina</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Galazolin | Halazolin | Imidin N | Nasenspray e | Nasenspray k | Nasentropfen e | Nasentropfen k | Nasolin | Olynth | Otrivin | Rhino Stas | Sinzyl | Sudafed Xylo | Xylo | Xylomethazoline | Xylorhin | Xymelin</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Balkis | Nasostop | Otrivin | Rhinex</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Amidrin | Frenasal | Otrivin | Rhinovin | Rinoblanco</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Nosil | Otrivin</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Nasment | Naso | Nasolin | Otrivin | Rinol | Zymelin</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Nazo | Nose | Otradrops | Otrivine | Sudafed | Sudafed blocked nose | Sudafed congestion relief | Tixycolds Cold and Allergy | Xylometazolin | Xylometazolin kent</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Hexarhinal | Otrivin | Otrivin moistur</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Decongestant | Nasal spray ii | Nazoline | Otrivin | Snup | Xyloma</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">MaxiRino | Meralys | Meralys HA | Olynth | Olynth ha</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Allenasal | Aquaspira | Huma-metazol | Lolimarine ha | Nasan | Novorin | Olynth | Otrivin | Rhino Stas F | Rhino-stas gy | Rinomaris | Snup | Xilomare</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Otrivin | Otrivin microdoser</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Otrivine | Sudafed</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Af Care | Nazalet | Otrivin | Xylovit</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Atrovin p | Biomist | Certen | Certen p | Clearnoz | Corex | Corivex | Corivin | Decon | Diconal | Goair | Hynasal XL | Lyftz | Mucoris | Nam Cold | Nam cold nasal drops | Naso wikoryl | Nasoflex | Nasomet | Nasomist x | Nazalin a | Nimza | Noblok | Nosikind | Nosikind P | Nostravin | Nosymed | Nozy | Orinase | Ortinose | Otrinoz | Otrivin | Pa cold paediatric | Recofast | Rhinoset | Rhinoset p | Rinostat XL | Sane | Sane p | Sinomet | Sinomet p | Wostrin | Xylo | Xylochek | Xylofree | Xylomist | Xyloris | Xynal | Zeecold | Zolex-forte | Zylo | Zylonasal</span>;</li>
<li>
<span class="countryCode">(IQ)</span> <span class="country">Iraq</span><span class="countrySeparator">: </span><span class="drugName">Otrinose</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Argotone Dec.Nas | Narhimed naso chiuso | Neo rinoleina | Otrivin | Otrivin ofta | Xilometazolina eg</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Decozal | Decozal colds | Decozoline | Otrivin | Xylomet</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Decozal | Ivynozvin A | Ivynozvin p | Otrivin | Otrivin children | Rhinovin adult | Rhinovin paediatric | Sinutab | Xylolin</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Bicoolong | Cinocaxylo | Colcare &amp; nasal | Coldaewon cona | Comekina nasal | Cotrobin | Cozatulin | Facol | Gelonasal | Metarivin | Minolnose | Narista xylo | Okotrin | Otrivin | S tuben</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Otrivin | Rhinex | Xylo comod | Xylolin | Xylomet</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Decozal | Otrivine | Xylo comod</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Galasolin | Galazolin | Halazolin | Imidin | Nasan | Nasen tropfen k | Nasenspray | Nomex | Nose | Olynth | Otrivin | Rhino Stas | Rhinostop | Sinzyl | Xylometazolin | Xylopharm | Xymelin</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Balkis nase | Nasan | Nasenspray | Nasentropfen k | Nasentropfen-k | Otrivine | Sinutab | Xylomaris</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Galasolin | Galazolin | Halazolin | Imidin N | Ksilonex | Nasan | Nasengel Rph | Nasenspray | Nasenspray Ratiopharm | Nasentropfen | Nomex | Olynth | Otrivin | Rhino Stas | Rhinostop | Sinzyl | Xylo | Xylometazolin | Xylometazoline | Xylopharm | Xymelin</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Otrivine</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Otrivina</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Otrivin</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Clarinez | Enaphrin | Otrivin | Xylone</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Albert Heijn Neusspray Xylometazoline HCl | Etos neusspray | Idyl neusdruppels xylometazoline hcl | Kinderneusdruppels | Kinderneusspray xylometazoline hcl htp | Kruidvat xylometazoline hcl | Livsane neusdruppels xylometazoline hcl | Neus | Neusdruppels voor de verstopte neus xylometa | Neusdruppels Xylometazoline HCL | Neusspray voor de verstopte neus xylometazoli | Neusspray Xylometazoline HCl | Otrivin | Otrivin care xylometazoline | Otrivin XylometazolineHCL | San xylometazoline hcl | Xylo comod | Xylometazoline HCL | Xylometazoline Hcl A | Xylometazoline Hcl Actavis | Xylometazoline HCl CF | Xylometazoline Hcl Kring | Xylometazoline HCl Mdq | Xylometazoline Hcl PCH | Xylometazoline HCl Sandoz</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Naso | Nazaren | Otrivin | Xolin | Xylometazolin norfri</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Coldrex</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Sinutab</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Otrivin | Xylonas | Xylone</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Lyzo | Metazolin | Nasavin | Xolisan | Xylometazoline | Xylonas | Xynosine</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Donosan | Otrivin | Sudafed xylospray dla dzieci | Xylometazolin | Xylometazolin vibrocil | Xylometazoline Coldact | Xylorin</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Otrivin | Triaminic Decongestant</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Nasexilo | Otrivina | Snup | Xymeral</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Otrivina</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Decozal | Otrivin Drops | Otrivin Menthol Spray | Otrivin Spray | Xylo-Acino | Xylolin Adult | Xylolin Children | Xylomet Adult | Xylomet Paediatric</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Bixtonim xylo | Bixtonim xylo aroma | Maresyl | Olynth | Rhinxyl | Snup | Xylo nasal</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Brizoline | Dlianos | Doctor theiss rhinotheiss | Dr. theiss rino | Espazoline | Eucazolin aqua | Fazin | Galazolin | Grippostad rhino | Halazolin | Influrin | Morelor xylo | Nazolin | Nosolin | Nosolin balsam | Olynth | Otrivin | Pharmazolin | Rhinomaris | Rhinonorm | Rhinorus | Rhinostop | Rinonorm | Sanorin xylo | Snup | Suprima nos | Tyzine | Tyzine xylo | Xylen | Xylen aktiv | Xylen neo | Xylobene | Xylometazol bufus | Xylometazolin | Xylometazoline | Xylometazoline Betalek | Xylometazoline bufus | Xylometazoline solopharm | Xymelin | Xymelin eco | Xymelin eco with menthol | Zvezdochka noz</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Decozal | Otrivin | Xylo | Xylolin | Xylomet</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Klarimax | Nasoferm | Otrivin | Teppix | Xylometazolin abece | Xylometazolin Apofri | Xylometazoline HCL | Zymelin</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Otrivin</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Maresyl | Maresyl ha | Olynth | Olynth ha | Snup</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Nasenspray | Olynth | Orinox neo | Otrivin | Rinoxyl</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Actavia | Otrivine</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Decozal</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Berkolin | Naze | Otrivine | Otrivine-Menthol | Rinizol | Sinotrin | Xylo comod</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Nasolin | Otrivin | Pen Ke Tong | Snup stada | Suzulex | Xyzoline</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Brizoline | Dlyanos | Dr.theiss nasal spray | Eucabal | Eucaphylipt xylo | Eucaspray | Eucazolin aqua | Evcaspray turbo | Farmazoline mint and eucalyptus | Galopril | Grippostad rhino | Halazolin | Meralys | Meralys advance | Multigrip nasal | Nazonol | Otrivin | Pharmazolin | Pharmazolin noviy | Rhinoxil | Rinazal | Rinomystin | Snup | Tyzine xylo | Xylo | Xylohexal | Xylometazolin | Xymelin</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Ivynozvin A | Otrivin</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Otrivina | Sinutab</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Elossy | Mucome | Syfazin | Thekati</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Nazovin | Otrivin | Sinutab nasal spray</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Biomist | Cirovin | Clarinez | Decon nasal drops | Ivynozvin A | Ivynozvin p | Otrivin | Sinutab | Xylone</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Otrivin</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Otrivin (xylometazoline). Mississauga, Ontario, Canada: Novartis Consumer Health Canada Inc. http://www.otrivin.ca/en-ca/products/. Accessed January 19, 2022.</div>
</li>
<li>
<div class="reference">
                  Otrivin (xylometazoline) [product monograph]. Mississauga, Ontario, Canada: Novartis Consumer Health Canada Inc; January 2016.</div>
</li></ol></div><div id="topicVersionRevision">Topic 106757 Version 74.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
